Originally published byDW News
BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its founders. Can its ambitious cancer trials turn it from a one-hit wonder into a biotech giant?
🇩🇪
More news from GermanyGermany
EUROPE
Related News
Bolivia miners clash with police, President Paz under fire
2h ago
British Gas customers to receive up to £112m in compensation over prepayment meters
2h ago
Cem Özdemir, first German state premier with Turkish roots
1d ago
Ceasefire in sight? What's next for Russia's war in Ukraine
1d ago
The race to understand how rat-virus spreads
1d ago